Ticker
VRCACompany Name
VERRICA PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Free Cash Flow | Free Cash Flow per Share | Share Factor | Weighted Average Shares |
---|---|---|---|---|
6/30/2025 | $ -47.35M | $ -4.99 | 1 | 9.49M |
3/31/2025 | $ -53.68M | $ -5.66 | 1 | 9.48M |
12/31/2024 | $ -60.95M | $ -11.76 | 1 | 5.18M |
9/30/2024 | $ -59.62M | $ -12.74 | 1 | 4.68M |
6/30/2024 | $ -65.93M | $ -14.18 | 1 | 4.65M |
3/31/2024 | $ -54.28M | $ -11.68 | 1 | 4.65M |
12/31/2023 | $ -38.94M | $ -8.59 | 1 | 4.53M |
9/30/2023 | $ -29.23M | $ -6.34 | 1 | 4.61M |
6/30/2023 | $ -12.6M | $ -2.74 | 1 | 4.59M |
3/31/2023 | $ -15.21M | $ -3.53 | 1 | 4.3M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
FCF / (Shares WA * Share Factor)
(=) FCFPS
FCFPS for VERRICA PHARMACEUTICALS INC is calculated as follows: FCF [ $ -33.25M ] / (Shares WA [ 2.5M ] * Share Factor [ 1 ])
(=) FCFPS [ $ -13.31 ]
Minimum
Jun 30, 2024
Maximum
Jun 30, 2023
Average
Median
filtered constituents | 3.76K |
---|---|
min | $ -7.96 |
max | $ 8.88 |
average | $ 0.8 |
median | $ 0.3 |
std | $ 2.82 |